Symbol
LYEL on Nasdaq
Investment type
Equity / Common Stock, par value $0.0001
Latest Disclosed Shares Owned
2,759,072 shares
Security Ownership %
13%

ARCH Venture Fund IX, L.P. ownership in Lyell Immunopharma, Inc. Common Stock, par value $0.0001 (LYEL)

14 Nov 2025 - ARCH Venture Fund IX, L.P. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 2,759,072 shares of Lyell Immunopharma, Inc. Common Stock, par value $0.0001 (LYEL). This represents 13% ownership of the company. This is the first filing by ARCH Venture Fund IX, L.P. disclosing ownership of Lyell Immunopharma, Inc. Common Stock, par value $0.0001 (LYEL).